Classical Hodgkin's Lymphoma
Also known as: Classic Hodgkin's Lymphoma / Classic Hodgkin Lymphoma / Classical Hodgkin Lymphoma / Classical Hodgkin lymphoma (disorder) / Classical Hodgkin lymphoma (morphologic abnormality) / Hodgkin lymphoma (morphologic abnormality) / Hodgkin granuloma (morphologic abnormality) / Hodgkin Disease / Hodgkin's disease / Hodgkin's disease (disorder) / Hodgkin lymphoma, no ICD-O subtype (morphologic abnormality) / Hodgkin's disease NOS (disorder) / Hodgkin's disease NOS / Hodgkin's granuloma (disorder) / Hodgkin's granuloma / Hodgkin granuloma [obs] (morphologic abnormality) / Hodgkin's granuloma NOS (disorder) / Hodgkin's paragranuloma -RETIRED- / Hodgkin's paragranuloma (disorder) / Hodgkin's paragranuloma / Hodgkin's paragranuloma NOS (disorder) / [M]Hodgkin's disease NOS (morphologic abnormality) / Hodgkin's disease, unspecified type / [M]Hodgkin's disease NOS / [M]Hodgkin's disease NOS (& [lymphogranuloma malignant]) / Hodgkin's granuloma of unspecified site (disorder) / Hodgkin's disease NOS, unspecified site (disorder) / Hodgkin's paragranuloma of unspecified site (disorder) / [M]Hodgkin's paragranuloma (morphologic abnormality) / Hodgins / Hodgkin lymphoma / [M]Lymphogranuloma, malignant (morphologic abnormality) / Lymphomas Hodgkin's disease / Hodgkin's lymphoma / Hodgkin lymphoma, nodular lymphocyte predominance (disorder) / Lymphogranulomatosis / Hodgkin lymphoma, nodular lymphocyte predominance (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB08870 | Brentuximab vedotin | A CD30-directed antibody-drug conjugate used to treat various types of lymphoma. |
| DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |